Perez, L., Fernandez, H., Kharfan-Dabaja, M., Khimani, F., Betts, B., Mishra, A., . . . Anasetti, C. (2021). A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention. Blood Adv.
Chicago Style CitationPerez, Lia, et al. "A Phase 2 Trial of the Histone Deacetylase Inhibitor Panobinostat for Graft-versus-host Disease Prevention." Blood Adv 2021.
Cita MLAPerez, Lia, et al. "A Phase 2 Trial of the Histone Deacetylase Inhibitor Panobinostat for Graft-versus-host Disease Prevention." Blood Adv 2021.
Atenció: Aquestes cites poden no estar 100% correctes.